<DOC>
	<DOC>NCT00082524</DOC>
	<brief_summary>This study is an open label, noncomparative study using an investigational agent for the treatment of documented Candida or Aspergillus infections in pediatric patients (ages 3 months-17 years).</brief_summary>
	<brief_title>Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043)</brief_title>
	<detailed_description />
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Aspergillosis</mesh_term>
	<mesh_term>Caspofungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>Children, 3 months through 17 years of age, with esophageal candidiasis or invasive candidiasis or children requiring salvage treatment of invasive aspergillosis.</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>